{"schemaVersion":"ready-scan.resource-sources.v1","locale":"zh-Hant","path":"/zh/sources/source-1003e63c165b448a","canonicalUrl":"https://readyscan.ai/zh/sources/source-1003e63c165b448a","machineUrl":"https://readyscan.ai/zh/discovery/sources/source-1003e63c165b448a.json","page":1,"pageSize":48,"totalCount":1,"totalPages":1,"previous":null,"next":null,"kind":"source","source":{"id":"source-1003e63c165b448a","url":"https://karamataclinical.com/expertise","title":"KARAMATA: /expertise","publisher":"karamataclinical.com","publicationCount":1,"modifiedOn":"2026-10-25","path":"/zh/sources/source-1003e63c165b448a","canonicalUrl":"https://readyscan.ai/zh/sources/source-1003e63c165b448a","machineUrl":"https://readyscan.ai/zh/discovery/sources/source-1003e63c165b448a.json"},"items":[{"key":"subject:Q141277596","citations":[{"id":"source-1003e63c165b448a","url":"https://karamataclinical.com/expertise","title":"KARAMATA: /expertise","publisher":"karamataclinical.com","accessedOn":"2026-10-25"}],"editions":[{"language":"en","title":"KARAMATA","description":"KARAMATA: “KARAMATA is an American clinical research services company specializing in hematology and oncology, with clinical research finance and regulatory disclosure services available across therapeutic areas.”","path":"/entities/karamata-q141277596","canonicalUrl":"https://readyscan.ai/entities/karamata-q141277596","machineUrl":"https://readyscan.ai/discovery/entities/karamata-q141277596.json","modifiedOn":"2026-10-25"}],"subject":{"slug":"karamata-q141277596","name":"KARAMATA","questions":[{"question":"01When should therapeutic strategy enter the operating plan?","path":"/entities/karamata-q141277596#company-answer-content-native-digital-agencies-75cf7cfeeb632825-a-eaa3df01a6d4e3fecbdf"},{"question":"02What inputs are needed to begin?","path":"/entities/karamata-q141277596#company-answer-content-native-digital-agencies-75cf7cfeeb632825-a-e3c21708389c31458219"},{"question":"03How are biomarkers connected to execution?","path":"/entities/karamata-q141277596#company-answer-content-native-digital-agencies-75cf7cfeeb632825-a-e13f4f3e7c14ea24b92b"},{"question":"04What does KARAMATA own?","path":"/entities/karamata-q141277596#company-answer-content-native-digital-agencies-75cf7cfeeb632825-a-01ea6ddbbbd2b5a8dca4"},{"question":"05What remains with the client?","path":"/entities/karamata-q141277596#company-answer-content-native-digital-agencies-75cf7cfeeb632825-a-dbe6e48eb6246d5d3b1f"},{"question":"06How are exceptions handled?","path":"/entities/karamata-q141277596#company-answer-content-native-digital-agencies-75cf7cfeeb632825-a-fe743884b9e3a712b674"}],"facts":[{"id":"content-native-digital-agencies-75cf7cfeeb632825-a-eaa3df01a6d4e3fecbdf","label":"01When should therapeutic strategy enter the operating plan?","value":"“Before design assumptions harden; early work should define evidence needs, decision gates, and ownership.”","path":"/entities/karamata-q141277596#company-fact-content-native-digital-agencies-75cf7cfeeb632825-a-eaa3df01a6d4e3fecbdf","questionPaths":["/entities/karamata-q141277596#company-answer-content-native-digital-agencies-75cf7cfeeb632825-a-eaa3df01a6d4e3fecbdf"]},{"id":"content-native-digital-agencies-75cf7cfeeb632825-a-e3c21708389c31458219","label":"02What inputs are needed to begin?","value":"“Disease setting, phase, modality, protocol concept, available evidence, and open decisions.”","path":"/entities/karamata-q141277596#company-fact-content-native-digital-agencies-75cf7cfeeb632825-a-e3c21708389c31458219","questionPaths":["/entities/karamata-q141277596#company-answer-content-native-digital-agencies-75cf7cfeeb632825-a-e3c21708389c31458219"]},{"id":"content-native-digital-agencies-75cf7cfeeb632825-a-e13f4f3e7c14ea24b92b","label":"03How are biomarkers connected to execution?","value":"“Selection, assay, sampling, endpoint, data, and operational implications are mapped together.”","path":"/entities/karamata-q141277596#company-fact-content-native-digital-agencies-75cf7cfeeb632825-a-e13f4f3e7c14ea24b92b","questionPaths":["/entities/karamata-q141277596#company-answer-content-native-digital-agencies-75cf7cfeeb632825-a-e13f4f3e7c14ea24b92b"]},{"id":"content-native-digital-agencies-75cf7cfeeb632825-a-01ea6ddbbbd2b5a8dca4","label":"04What does KARAMATA own?","value":"“The engagement scope defines analysis, planning, documentation, coordination, and decision support.”","path":"/entities/karamata-q141277596#company-fact-content-native-digital-agencies-75cf7cfeeb632825-a-01ea6ddbbbd2b5a8dca4","questionPaths":["/entities/karamata-q141277596#company-answer-content-native-digital-agencies-75cf7cfeeb632825-a-01ea6ddbbbd2b5a8dca4"]},{"id":"content-native-digital-agencies-75cf7cfeeb632825-a-dbe6e48eb6246d5d3b1f","label":"05What remains with the client?","value":"“Program direction, approvals, regulatory and legal judgments, and release authority remain explicit.”","path":"/entities/karamata-q141277596#company-fact-content-native-digital-agencies-75cf7cfeeb632825-a-dbe6e48eb6246d5d3b1f","questionPaths":["/entities/karamata-q141277596#company-answer-content-native-digital-agencies-75cf7cfeeb632825-a-dbe6e48eb6246d5d3b1f"]},{"id":"content-native-digital-agencies-75cf7cfeeb632825-a-fe743884b9e3a712b674","label":"06How are exceptions handled?","value":"“Open questions, assumptions, disagreements, and unresolved evidence are documented and escalated.”","path":"/entities/karamata-q141277596#company-fact-content-native-digital-agencies-75cf7cfeeb632825-a-fe743884b9e3a712b674","questionPaths":["/entities/karamata-q141277596#company-answer-content-native-digital-agencies-75cf7cfeeb632825-a-fe743884b9e3a712b674"]}]},"selected":{"language":"en","title":"KARAMATA","description":"KARAMATA: “KARAMATA is an American clinical research services company specializing in hematology and oncology, with clinical research finance and regulatory disclosure services available across therapeutic areas.”","path":"/entities/karamata-q141277596","canonicalUrl":"https://readyscan.ai/entities/karamata-q141277596","machineUrl":"https://readyscan.ai/discovery/entities/karamata-q141277596.json","modifiedOn":"2026-10-25"}}],"versionId":"fnv1a64:6f3b0cb87de3b906"}